Compound Description

Myristic acid, 9-ester with 1,1aα,1bβ,4,4a,7aα,7b,8,9,9a-decahydro-4aβ,7bα,9β,9aα-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8α-tetramethyl-5H-cyclopropa[3,4]benz[1,2-e]azulen-5-one 9a-acetate, (+)-;

Tetradecanoic acid, 9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl ester, [1aR-(1aα,1bβ,4aβ,7aα,7bα,8α,9β,9aα)]-;

1H-Cyclopropa[3,4]benz[1,2-e]azulene, tetradecanoic acid deriv.;

12-O-Tetradecanoylphorbol 13-acetate;

12-Tetradecanoylphorbol 13-acetate;

12-Tetradecanoylphorbol 13-monoacetate;

13-O-Acetylphorbol 12-myristate;

4β-Phorbol 12-myristate 13-acetate;

Factor A1;

Factor A1 (croton oil);

NSC 262244;

PD 616;

PMA;

PMA (tumor promoter);

Phorbol 12-myristate 13-acetate;

Phorbol 12-tetradecanoate 13-acetate;

Phorbol myristate acetate;

TPA;

TPA (phorbol derivative);

Tetradecanoylphorbol acetate;

β-Phorbol 12-myristate 13-acetate